(Q83347969)
Statements
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study (English)
G Corazzelli
F Russo
G Capobianco
G Marcacci
P Della Cioppa